1. Edition - November 2008
38.90 Euro
2008. 100 Pages, Softcover
- Professional Book -
ISBN-10: 1-4051-5575-2
ISBN-13: 978-1-4051-5575-5 - John Wiley & Sons






Sample Chapter

Short description
Cardiovascular Risk Management

Edited by Professor Richard Hobbs, University of Birmingham. UK and Dr Bruce Arroll, University of Auckland, New Zealand

Cardiovascular Risk Management provides a comprehensive, practical, easy-reference guide to encourage appropriate management of cardiovascular disease and implementation of the many guidelines and risk assessment methods available for this purpose.

This brand new book enables doctors to prioritise treatment using risk-scoring systems and holistic recommendations for reducing cardiovascular risk, providing an overview of why it is important to prevent and treat cardiovascular disease, how to achieve this and the key cardiovascular guidelines available. It includes core guideline recommendations and areas of discrepancy between guidelines, the different risk calculators, treatment recommendations and emerging risk factors and therapies, as well as treatment plans for individuals with diabetes who are at high risk of developing cardiovascular disease.

This is an ideal text for general practitioners, junior doctors, medical students and nurses.

Titles of related interest:

Cardiovascular Critical Care, Griffiths, 9781405148573

Swanton's Cardiology, 6th Edition, Swanton, 9781405178198

From the contents
1. Epidemiology of cardiovascular disease.

2. Using guidelines as a framework for holistic risk management.

3. Screening & identifying at-risk patients.

4. Moderate- to low-risk patients - management recommendations.

5. High-risk patients - management recommendations.

6. Type 2 diabetes and metabolic syndrome patients - management recommendations for reducing cardiovascular risk.

7. Lifestyle changes to reduce cardiovascular risk.

8. Pharmacotherapy - improving the lipid profile.

9. Pharmacotherapy - lowering blood pressure.

10. Pharmacotherapy - lowering blood glucose.

11. Long-term management of cardiovascular disease.

12 Managing cardiovascular risk in the future - developments in the pipeline